The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Choosing Your MedsChoosing Your Meds
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  • Email Email
  • Glossary Glossary

starting medicine

Dec 8, 2007

I am going to be starting meds which is better viramene or kaletra and epizocom.

Response from Dr. Wohl

Better at what? Both Viramune and Kaletra are potent HIV meds and they are both twice a day. The drugs have not been compared head-to-head but Kaletra and Sustiva (Stocrin) have and we know that Sustiva was better at getting the viral load below 50 copies/mL but Kaletra produced modestly higher CD4 cell count increases. Both were well tolerated. Resistance to Viramune and Sustiva is easier to develop compared to Kaletra if adherence is not optimal.

In the US, most HIV doctors would favor Kaletra over Viramune, given the lack of recent data with Viramune. Not also that Viramune is not a good option for those with higher CD4 cell counts due to increased risk of liver and skin adverse effects. The selection between Kaletra and Sustiva is more difficult given the results of the study mentioned above and differences in formulations and toxicities.

For Epzicom, it is now recommended that tests be done to make certain you are not at risk for a hypersensitivity reaction.


getting better or not??

  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint